Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04824703
Other study ID # Aswu/460/5/20
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 5, 2021
Est. completion date May 11, 2023

Study information

Verified date April 2024
Source Aswan University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess the benefits and drawbacks of high versus low oxygen therapy on mortality and myocardial function in mechanically ventilated patients


Recruitment information / eligibility

Status Completed
Enrollment 106
Est. completion date May 11, 2023
Est. primary completion date May 5, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - adults aged 18 years or older admitted to ICU and expected to receive mechanical ventilation beyond next calendar day Exclusion Criteria: - inclusion in other trial - severe acute respiratory distress syndrome at time of admission - acute Chronic obstructive airway disease exacerbation - pregnancy - Carbon monoxide poisoning - Guillain Barre syndrome

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Oxygen
Decreasing fraction of inspired oxygen and its effect on mortality and myocardial function administered by invasive mechanical ventilation with fraction of inspired oxygen between 0.21 and 1

Locations

Country Name City State
Egypt Aswan university hospital Aswan

Sponsors (1)

Lead Sponsor Collaborator
Aswan University Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Stroke volume in milliliters Volume of blood in milliliters that is ejected from heart each second and measured By Echocardiography Change from Baseline stroke volume At ICU admission and through study completion An average 6 months
Primary Change in ejection fraction of heart in percentage percentage of blood that's pumped out of a filled ventricle with each heartbeat And measured by echocardiography Change from baseline ejection fraction at icu admission and through study completion An Average 6 months
Secondary Acute respiratory distress syndrome Acute persistent hypoxia with bilateral lung infiltrate due to non cardiac cause From icu admission date to icu discharge date an average of 2 weeks
Secondary Sepsis Systolic blood pressure < 90 Respiratory rate > 22 Heart rate > 100 From icu admission date to icu discharge date an average of 2 weeks
Secondary Stroke Cerebrovascular accidents From icu admission date to icu discharge date an average of 2 weeks
Secondary Mechanical Ventilator free days Days without mechanical ventilation From icu admission date to icu discharge date an average of 2 weeks
Secondary Shock Systolic blood pressure < 90 mmHg From icu admission date to icu discharge date an average of 2 weeks
Secondary Surgery revision Surgical re exploration From icu admission date to icu discharge date an average of 2 weeks
Secondary Vasopressor Use of vasopressors as norepinephrine and epinephrine From icu admission date to icu discharge date an average of 2 weeks
Secondary ICU stay Duration of intensive care stay From icu admission date to icu discharge date an average of 2 weeks
Secondary Hospital stay Duration of hospital stay From icu admission date to icu discharge date an average of 2 weeks
Secondary Mortality Death of patient From icu admission date to icu discharge date an average of 2 weeks
See also
  Status Clinical Trial Phase
Completed NCT02943863 - Regional Ventilation During High Flow Nasal Cannula and Conventional Nasal Cannula in Patients With Hypoxia N/A
Recruiting NCT05029167 - REstrictive Versus LIberal Oxygen Strategy and Its Effect on Pulmonary Hypertension After Out-of-hospital Cardiac Arrest (RELIEPH-study) N/A
Completed NCT05112172 - Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500m N/A
Recruiting NCT06110390 - High-flow Nasal Oxygen Therapy to Prevent Extubation Failure in Adult Trauma Intensive Care Patients N/A
Completed NCT05677009 - Sustainable Preservation of Essential Oxygen Resources: A Phase 4 Crossover Study of the BUFEO System: SAVE O2 N/A
Recruiting NCT06037915 - Airway Interventions During Intravenous Anesthesia in Children Undergoing Direct Laryngoscopy for Surgical Procedures Using High Flow Nasal Versus Low Flow Oxygen. A Pilot Study.(Flowkid) Phase 4
Recruiting NCT04866342 - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor N/A
Completed NCT02599246 - FiO2 in Chronic Obstructive Pulmonary Disease (COPD) Patient Normobaric O2 Versus NIV N/A
Completed NCT03607357 - High Flow Nasal Oxygen and Acute Left Heart Failure N/A
Recruiting NCT05401474 - Individualization Flow in Patients Treated With High Flow Nasal Therapy (iFLOW) N/A
Completed NCT01575327 - Closed-loop System for Oxygen Delivery and Exercise in Chronic Obstructive Pulmonary Disease N/A
Recruiting NCT04842253 - HFNC vs LFNC in Patients With AF Undergoing RFCA Under Deep Sedation. N/A
Completed NCT05688189 - Initial Temperature of High Flow Nasal Cannula N/A
Completed NCT04177992 - Servo Controlled Oxygen Targeting Study N/A
Recruiting NCT05511636 - Comparing The Outcome Of High Flow Oxygen Versus Conventional Oxygen In Extubated Patients After Lung Resection. N/A
Completed NCT04363463 - Impact of Prone Position in Patients Under Spontaneous Breathing on Intubation or Non-invasive Ventilation or Death Incidence During COVID-19 Acute Respiratory Distress N/A
Terminated NCT04546568 - SCO2T (Servo vs. Servo) N/A
Completed NCT03431818 - Effective Fraction of Inspired Oxygen With Nasal Cannula in Premature Infants
Completed NCT04965844 - Closed-loop Oxygen Control for High Flow Nasal Therapy N/A